What the changes say
- New risks center on PFAS litigation, tariff volatility, AI-related information disclosure, and restrictive $285 million debt financing.
- Regulatory exposure now emphasizes FIFRA pre-emption uncertainty and continuing EPA warnings about DCPA.
- Customer concentration improved slightly, with top-three customers representing 36% of 2025 sales versus 38% in 2024.
- Several previously highlighted risks, including PCNB cancellation, climate volatility, acquisitions, and technology investments, were removed.
What changed since the prior 10-K
New
- NewRegulatory/ Supply Chain/Other Risks
PFAS lawsuits and legislation continue to spread among many states
PFAS legislation and lawsuits could affect the Company or its products even though it does not sell PFAS-containing products.
- NewRegulatory/ Supply Chain/Other Risks
Tariffs continue to cause disruption within the Company’s markets
Unpredictable tariffs are disrupting agricultural markets, domestic crop trade, and growers’ input costs, potentially reducing the Company’s financial performance.
- NewRegulatory/ Supply Chain/Other Risks
Use of Artificial Intelligence could lead to the disclosure of sensitive information
Employees’ use of public AI tools could transmit sensitive Company information to AI providers.
- NewCredit and Other Risks
The Company’s new debt structure limits its liquidity, requires defined, minimum levels of financial performance and includes significant interest expense, and the Company may not be able to refinance on terms favorable to the Company or execute on business opportunities that may otherwise be advantageous to the Company
The March 2026 refinancing adds $225 million first-lien and $60 million second-lien loans, high interest, liquidity minimums, and financial covenants that could constrain operations and growth.
Dropped
- DroppedRegulatory/ Supply Chain/Other Risks
USEPA has issued a proposed final decision (“PFD”) to cancel PCNB
- DroppedRegulatory/ Supply Chain/Other Risks
The distribution and sale of the Company’s products are subject to governmental approvals and thereafter ongoing governmental regulation
- DroppedRegulatory/ Supply Chain/Other Risks
Climate Change may adversely affect the Company’s business
- DroppedRegulatory/ Supply Chain/Other Risks
The highly competitive nature of our markets could adversely affect our ability to maintain or grow revenues
Potential USEPA cancellation of PCNB, a fungicide used on golf courses, potatoes, and other applications.
- DroppedTransformation/Credit and Other Risks
The Company’s transformation initiatives may not generate the full benefit of targeted efficiencies
- DroppedTransformation/Credit and Other Risks
Reduced financial performance may limit the Company’s ability to borrow under its credit facility
- DroppedAcquisition/Investment Risks
Newly acquired businesses or product lines may not generate forecasted results
- DroppedAcquisition/Investment Risks
The Company’s investment in technology may not generate forecasted returns
- DroppedAcquisition/Investment Risks
Industry consolidation may threaten the Company’s position in various markets
Reworded
- 63% rewrittenRegulatory/ Supply Chain/Other Risks
Compliance with environmental and other regulations or changes in such regulations or regulatory enforcement priorities could increase our cost of doing business or limit our ability to market all our products
No substantive change; the risk remains focused on pesticide registrations, cancellations, and regulatory scrutiny.
- 60% rewrittenRegulatory/ Supply Chain/Other Risks
Our business, financial condition and results of operations could be materially affected by disruptions in the global supply chain, including risks associated with sourcing and manufacturing outside of the U.S. and risks from tariffs and/or international trade wars
Adds increased tariffs to the previously identified military conflict, trade-barrier, and global supply-chain disruption risks.
- 53% rewrittenRegulatory/ Supply Chain/Other Risks
The trend of passing pesticide “ban-bills” in various states could put one or more of the Company’s products at risk
Adds uncertainty over whether FIFRA pre-empts state failure-to-warn claims, now before the U.S. Supreme Court.
- 41% rewrittenAcquisition/Investment Risks
The Company’s customer base is relatively concentrated, with a small number of customers accounting for a significant portion of our sales
Top-three customer concentration declined from 38% of 2024 sales to 36% of 2025 sales.
- 41% rewrittenCredit and Other Risks
Domestic and regional inflation trends, increased interest rates and other factors could lead to the erosion of economies and adversely impact the Company
Notes 2025 U.S. interest-rate cuts but warns inflation and related conditions could materially harm future financial performance.
- 34% rewrittenRegulatory/ Supply Chain/Other Risks
Public statements made by USEPA regarding their preliminary findings in connection with the registration review of DCPA could expose the Company to future claims for personal injury which, in turn, could adversely affect the Company’s financial performance
Removes Dacthal sales suspension and cancellation details, while adding repeated EPA warnings about potential user risks despite no known injury.
All 26 risk factors
Headings as the filing states them, in filing order.
Regulatory/ Supply Chain/Other Risks
- 01Compliance with environmental and other regulations or changes in such regulations or regulatory enforcement priorities could increase our cost of doing business or limit our ability to market all our products63% rewritten
- 02Public statements made by USEPA regarding their preliminary findings in connection with the registration review of DCPA could expose the Company to future claims for personal injury which, in turn, could adversely affect the Company’s financial performance34% rewritten
- 03Several of the Company’s organophosphates are subject to a petition to revoke tolerances under the FFDCA which, if granted, could result in the limitation and/or cancellation of one or more registrations for such products
- 04Product liability judgments on glyphosate and cases involving other pesticides by domestic courts present a litigation risk to companies in this industry
- 05The trend of passing pesticide “ban-bills” in various states could put one or more of the Company’s products at risk53% rewritten
- 06PFAS lawsuits and legislation continue to spread among many statesNew
- 07Use of the Company’s products is subject to continuing challenges from activist groups
- 08The Company is dependent upon sole source or a limited number of suppliers for certain of its raw materials and active ingredients
- 09Our business, financial condition and results of operations could be materially affected by disruptions in the global supply chain, including risks associated with sourcing and manufacturing outside of the U.S. and risks from tariffs and/or international trade wars60% rewritten
- 10The manufacturing of the Company’s products is subject to governmental regulations
- 11Tariffs continue to cause disruption within the Company’s marketsNew
- 12A change in tax laws, treaties or regulations, or their interpretation or application, could have a negative impact on our business and results of operations
- 13Use of Artificial Intelligence could lead to the disclosure of sensitive informationNew
- 14Our business is subject to fluctuations and volatility in the global economy
- 15The Company’s business may be adversely affected by weather effects and commodity prices
- 16The Company may be subject to environmental liabilities
Credit and Other Risks
- 17The Company’s new debt structure limits its liquidity, requires defined, minimum levels of financial performance and includes significant interest expense, and the Company may not be able to refinance on terms favorable to the Company or execute on business opportunities that may otherwise be advantageous to the CompanyNew
- 18The Company depends in part upon customer prepayments to meet its working capital needs
- 19The carrying value of certain assets on the Company’s consolidated balance sheets may be subject to impairment depending upon market trends and other factors
- 20The Company’s computing systems are subject to cyber security risks
- 21To the extent that capacity utilization is not fully realized at its manufacturing facilities, the Company may experience lower profitability
- 22Domestic and regional inflation trends, increased interest rates and other factors could lead to the erosion of economies and adversely impact the Company41% rewritten
Acquisition/Investment Risks
- 23The Company’s investment in foreign businesses may pose additional risks
- 24The Company’s growth has been fueled in part by acquisitions
- 25The Company faces competition from generic competitors that source products from countries having lower cost structures
- 26The Company’s customer base is relatively concentrated, with a small number of customers accounting for a significant portion of our sales41% rewritten
Other American Vanguard 10-Ks
- FY2024 10-K risk factors31 risks
Product-specific EPA threats dominate: DCPA, organophosphates, and PCNB face registration, tolerance, or cancellation actions.
Filed May 29, 2025
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.